Real-World Survival Outcomes and Prognostic Factors Among Patients Receiving First Targeted Therapy for Advanced Renal Cell Carcinoma: A SEER–Medicare Database Analysis

Clinical Genitourinary Cancer - United States
doi 10.1016/j.clgc.2016.12.005
Full Text
Abstract

Available in full text

Categories
OncologyUrology
Date
Authors
Publisher

Elsevier BV

Related search

Survival of Patients Receiving Systematic Therapy for Metachronous or Synchronous Metastatic Renal Cell Carcinoma: A Retrospective Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Real‐World Assessment of Clinical Outcomes Among First‐Line Sunitinib Patients With Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group

Oncologist
Cancer ResearchMedicineOncology
2020English

Targeted Therapy for Renal Cell Carcinoma

2011English

Prognostic Factors in Patients With Renal Cell Carcinoma

Japanese Journal of Urology
Urology
1999English

Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy in the United States: A SEER Analysis

World Journal of Urology
Urology
2012English

PCN10 Targeted Therapy (TT) for First Line Treatment of Advanced Renal Cell Carcinoma (RCC): An Indirect Comparison Meta-Analysis (ICMA)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Outcomes of Patients With Metastatic Renal Cell Carcinoma and End-Stage Renal Disease Receiving Dialysis and Targeted Therapies: A Single Institution Experience

Clinical Genitourinary Cancer
OncologyUrology
2014English

Real-World Clinical Outcomes of Pazopanib Immediately Following Immunotherapy Discontinuation for the Treatment of Advanced Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2020English

Survival and Prognostic Factors for Patients With Advanced Hepatocellular Carcinoma After Stereotactic Ablative Radiotherapy

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy